Market Place
Sourcing Support
AACR: Genentech veteran engineers ‘smart’ cancer drug startup
19 Apr 2026 //
FIERCE BIOTECH
Novocure Touts Positive Data In Metastatic Pancreatic Cancer
27 Mar 2026 //
FIERCE BIOTECH
Roche Halts SMA Drug, Boosting Rivals` Prospects
20 Mar 2026 //
BIOSPACE
Genentech Shreds RIPK1 Inhibitor After Ph. 2 Failure
19 Mar 2026 //
FIERCE BIOTECH
Genentech`s Gazyva Reduces Lupus Activity In Phase III Data
06 Mar 2026 //
PHARMIWEB
Genentech Announces Positive Phase II Results for Petrelintide
05 Mar 2026 //
PHARMIWEB
Genentech’s Fenebrutinib Shows Phase 3 Success in MS Trials
02 Mar 2026 //
PHARMIWEB
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Roche Announces Positive Phase III Results For Gazyva/Gazyvaro
17 Feb 2026 //
GLOBENEWSWIRE
Genprex To Receive Patent In Australia For Reqorsa Gene Therapy
10 Feb 2026 //
PR NEWSWIRE
Genentech`s Fenebrutinib Reduces Disability Progression
07 Feb 2026 //
PHARMIWEB
Roche Continues RNA Return With $1.7B Deal For Sanegene Drug
03 Feb 2026 //
FIERCE BIOTECH
Biotech Showcase Facilitates Investor, Pharma, And Media Access
08 Jan 2026 //
PHARMIWEB
Ollin Eyes Phase 3 After Topping Vabysmo In Early-Stage Trial
08 Jan 2026 //
FIERCE BIOTECH
FDA Approves Roche`s Lunsumio VELO For Subcutaneous Use
22 Dec 2025 //
GLOBENEWSWIRE
Redhill Bio Opaganib Shows Promise In Venetoclax-Resistant Cells
15 Dec 2025 //
PR NEWSWIRE
Genentech`s Giredestrant Cuts Er-Positive Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Genentech Reveals Lunsumio Data In Early Lymphoma Treatment Lines
08 Dec 2025 //
BUSINESSWIRE
Roche`s Experimental MS Drug Hits Main Goal in One of Two Trial
09 Nov 2025 //
BUSINESSWIRE
Positive Phase III Data for Genentech’s Gazyva for Lupus
03 Nov 2025 //
BUSINESSWIRE
Genentech`s Tecentriq Demonstrates Major Survival Gains
20 Oct 2025 //
PHARMIWEB
Genentech Presents Ph3 Data for Vamikibart in UME
17 Oct 2025 //
PHARMIWEB
Genentech Showcases Science And Cancer Care Advances At ESMO 2025
14 Oct 2025 //
BUSINESSWIRE
Roche Showcases Science And Cancer Care Advances At ESMO 2025
13 Oct 2025 //
GLOBENEWSWIRE
Genentech Awarded $124M In Cabilly Patent Dispute With Biogen
06 Oct 2025 //
FIERCE PHARMA
Genentech Unveils Ocrevus, Fenebrutinib Data At ECTRIMS 2025
24 Sep 2025 //
BUSINESSWIRE
Roche Prsent Ocrevus And Fenebrutinib Data at ECTRIMS 2025
24 Sep 2025 //
GLOBENEWSWIRE
Roche Reports Phase 3 Breast Cancer Victory for Oral Serd
24 Sep 2025 //
FIERCE BIOTECH
Starpharma`s Collaboration and License Agreement with Genentech
22 Sep 2025 //
GLOBENEWSWIRE
Eye Disease Biotech Launches with $100M, Roche Rival in Clinic
17 Sep 2025 //
FIERCE BIOTECH
Genentech`s Vabysmo Data Reinforce Efficacy, Safety in Wet AMD
05 Sep 2025 //
PHARMAWEB
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
03 Sep 2025 //
BIOSPACE
Nykode Bets Future on Cancer Trial After Losing Genentech Pact
27 Aug 2025 //
FIERCE BIOTECH
Genentech, Roche Begin Construction on Advanced Manufacturing
25 Aug 2025 //
BUSINESSWIRE
Genentech Scraps $ 2B Deal with Cell Therapy Biotech
19 Aug 2025 //
FIERCE BIOTECH
AZ, Genentech, Merck top oncology HCP promotions: report
14 Aug 2025 //
FIERCE PHARMA
Genentech Susvimo Maintains Vision 5 Years in Wet AMD Patients
01 Aug 2025 //
BUSINESSWIRE
Roche`s Alzheimer`s Antibody Reduces Amyloid Plaques in 7 Months
28 Jul 2025 //
BIOSPACE
Genentech`s Itovebi Extends Survival in HR-positive Breast Cancer
31 May 2025 //
BUSINESSWIRE
Genentech`s Columvi Extends Survival in Lymphoma Patients
23 May 2025 //
BUSINESSWIRE
FDA Approves Genentech`s Susvimo for Diabetic Retinopathy
22 May 2025 //
BUSINESSWIRE
Genentech Bets Again on Orionis With $2B+ in Glue Space
22 May 2025 //
BIOSPACE
Genentech Update on FDA Meeting for Columvi in Lymphoma
20 May 2025 //
BUSINESSWIRE
Genentech honors hemophilia A caregivers in Hemlibra short film
14 May 2025 //
FIERCE PHARMA
10-Year Data: Perjeta Regimen Cuts Breast Cancer Deaths
13 May 2025 //
BUSINESSWIRE
Genentech builds autoimmune Repertoire with $765M deal
24 Apr 2025 //
FIERCE BIOTECH
Genentech and Roche reveal Alzheimer`s advancements at AD/PD 2025
03 Apr 2025 //
BUSINESSWIRE
Genentech Updates Ocrevus High Dose Study in Multiple Sclerosis
02 Apr 2025 //
BUSINESSWIRE
FDA Accepts sBLA For Genentech’s Gazyva In Lupus Nephritis
06 Mar 2025 //
BUSINESSWIRE
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
04 Mar 2025 //
PRESS RELEASE
FDA Approves Roche’s Susvimo in Diabetes-related Blindness
04 Feb 2025 //
GLOBENEWSWIRE
Genprex Doses Patient In Acclaim-3 Phase 2 Study For Lung Cancer
23 Jan 2025 //
PR NEWSWIRE
Genentech’s Prasinezumab Ph IIb Miss Primary Endpoint in Parkinson
19 Dec 2024 //
BUSINESSWIRE
Genentech’s Polivy Combo is New Standard for Untreated Lymphoma
09 Dec 2024 //
BUSINESSWIRE
Genentech Updates Columvi, Lunsumio Data at ASH 2024 for Lymphoma
09 Dec 2024 //
BUSINESSWIRE
FDA Accepts sBLA For Genentech`s Columvi Combo For R/R DLBCL
05 Dec 2024 //
BUSINESSWIRE
COUR Signs Licensing Deal with Genentech for Autoimmune Therapy
03 Dec 2024 //
GLOBENEWSWIRE
Genentech axes Nykode cancer vaccine deal
09 Nov 2024 //
FIERCE BIOTECH
Roche MAGE-A4 trial withdrawn after strategic review
19 Oct 2024 //
FIERCE BIOTECH
Genentech’s Vabysmo Improves Vision In DME Underrepresented Groups
18 Oct 2024 //
BUSINESSWIRE
